FdaApplication

ANDA 212015

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMA INC
application_typeANDA
approval_date2020-07-06

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL

2 products